← Open Payments lookup

DANIEL LAM: Open Payments

NPI 1144311127 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$646 in 29 payments from 7 companies in 2025. Trend: 2023 $682 · 2024 $329 · 2025 $646

Food & beverage: $646
CompanyPaymentsAmount
Axsome Therapeutics, Inc.9$276
Supernus Pharmaceuticals, Inc.10$124
Otsuka America Pharmaceutical, Inc.4$91
Neurocrine BioSciences, Inc.2$50
Teva Pharmaceuticals USA, Inc.2$47
ABBVIE INC.1$30
E.R. Squibb & Sons, L.L.C.1$28

Products named: Auvelity, Qelbree, REXULTI, INGREZZA, AUSTEDO XR, VRAYLAR, COBENFY, ABILIFY ASIMTUFII.

Industry payments across WA — which companies pay providers there.